Biomedical engineers at Duke University have shown that the effectiveness of a two-pronged type 2 diabetes treatment increases when the drugs are linked by a heat-sensitive tether rather than concurrently administered. The combination molecule forms a gel-like depot under the skin that slowly releases the drug. These findings suggest that this approach to combination drug design could be applied to disease therapies beyond diabetes.
- After CDC guidance, little change in opioid prescriptions to those at risk of misuse
- Once in a lifetime floods to become regular occurrences by end of century
- RUDN University physicists described a new type of amorphous solid bodies
- Incredible vision in ancient marine creatures drove an evolutionary arms race
- Why does it matter if most Republican voters still think Biden lost?